Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Infant Formula Recalled: Botulism Investigation

November 12, 2025 Victoria Sterling Business
News Context
At a glance
  • On ⁢February 28, 2024, ByHeart, a direct-to-consumer infant formula⁤ company, initiated ‌a voluntary recall ​of two ‌specific batches of its Whole⁤ Nutrition Infant Formula.
  • Consumers can‍ find the batch number and best by ‌date printed on‍ the⁤ bottom of the can.
  • Infant botulism is a rare illness ⁣caused by⁣ the bacterium‌ Clostridium botulinum.
Original source: nytimes.com

“`html

ByHeart Infant Formula ⁣Recall: Botulism Concerns⁤ and What Parents Need to Know

Table of Contents

  • ByHeart Infant Formula ⁣Recall: Botulism Concerns⁤ and What Parents Need to Know
    • At ⁣a glance
    • What Happened: ‌the ByHeart Formula‍ Recall
    • Understanding Infant botulism
    • What does This Mean⁣ for Parents?
    • ByHeart’s Response and Ongoing Investigation

Updated February 29, 2024

At ⁣a glance

  • What: Voluntary recall of two batches of ByHeart Whole Nutrition Infant Formula due⁢ to a cluster of infant botulism ‍cases.
  • Where: ⁢Nationwide distribution ‍in the ‌United States.
  • When: Recall ⁢announced February 28, 2024.
  • Why it Matters: Infant botulism is a serious illness that can cause ​muscle weakness,​ difficulty breathing, and even death.
  • What’s Next: ⁣parents should immediately ​stop using the⁢ recalled formula⁤ and contact their healthcare provider.

What Happened: ‌the ByHeart Formula‍ Recall

On ⁢February 28, 2024, ByHeart, a direct-to-consumer infant formula⁤ company, initiated ‌a voluntary recall ​of two ‌specific batches of its Whole⁤ Nutrition Infant Formula. This action ​followed ⁤reports of an increase in cases of infant botulism, a rare but serious illness, among infants ‌who had consumed ⁤the ⁤product. The recall was made in cooperation with the Food and Drug Administration (FDA) ​and the Centers for⁣ Disease​ Control and Prevention (CDC).

The⁣ affected batches‍ are:

Batch Number Best By Date UPC Code
24181 08/08/2024 850033236089
24190 08/10/2024 850033236089

Consumers can‍ find the batch number and best by ‌date printed on‍ the⁤ bottom of the can.

Understanding Infant botulism

Infant botulism is a rare illness ⁣caused by⁣ the bacterium‌ Clostridium botulinum. Unlike adult botulism, which ⁣ofen results ⁣from improperly canned foods, ‍infant botulism typically‌ occurs ‌when​ infants⁢ ingest spores of the bacteria. These spores can germinate ‍in the infant’s immature digestive system, producing⁣ a hazardous neurotoxin.

Symptoms of infant botulism​ can include:

  • Constipation
  • Weak cry
  • Lethargy (floppiness)
  • Difficulty feeding
  • Weakness
  • Difficulty breathing

Early diagnosis and treatment ⁤with antitoxin are crucial. If ⁤you suspect your infant has botulism, seek immediate medical attention.

What does This Mean⁣ for Parents?

The FDA and CDC are currently investigating the source of the Clostridium botulinum ⁤ contamination. While the‍ investigation‍ is ongoing, the ⁤immediate priority is⁣ to protect infants. Parents and caregivers who⁢ have purchased the recalled ByHeart ​formula ⁢should immediately discontinue use and dispose of the product.

do⁣ not attempt⁢ to return the ⁢formula to the store.contact byheart directly for ⁣a refund or replacement.

If your infant has⁣ consumed the ⁤recalled formula and is exhibiting any symptoms of botulism, contact​ your‌ pediatrician or seek emergency ‍medical care immediately. Early intervention substantially improves outcomes.

ByHeart’s Response and Ongoing Investigation

ByHeart has stated that it is cooperating fully with the FDA‌ and⁤ CDC investigation. ‌The‌ company has⁢ paused‍ production of‍ the affected batches and⁣ is working to determine the⁣ root cause ​of‌ the ⁤contamination. ⁢ ByHeart emphasizes its commitment to infant safety and quality control.

We‍ are⁣ deeply ⁤concerned ⁢by⁢ these reports and are taking‌ every‍ possible step ⁤to protect ​the infants we⁤ serve.Our ⁤commitment to quality and safety remains⁢ unwavering.

The FDA is⁢ conducting a thorough review‍ of ByHeart’s ⁤manufacturing processes and quality control procedures. The investigation will likely focus on identifying potential sources of contamination, including raw materials,

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service